Actively Recruiting
Comparison of High Flow Nasal Oxygen and Nasal Cannula in Burn Patients Under Sedation
Led by Ankara City Hospital Bilkent · Updated on 2025-01-03
70
Participants Needed
1
Research Sites
30 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Burn-related pain is severe and often difficult to manage. Burn patients often require high doses of opioids and anxiolytics. Anesthetic agents used during sedation such as benzodiazepines, propofol and opioids can cause respiratory depression, predisposing patients to hypoventilation and hypoxemia due to airway obstruction. Oxygen is administered to patients with a standard nasal cannula during sedation. High Flow Nasal Oxygen (HFNO) helps to improve the oxygenation of patients with respiratory distress by delivering high flow humidified oxygen through the nasal cannula at a high rate of up to 40-70 liters per minute. The aim of this study was to compare the effects of HFNO and nasal oxygen therapy in preventing hypoxemia in deeply sedated burn patients.
CONDITIONS
Official Title
Comparison of High Flow Nasal Oxygen and Nasal Cannula in Burn Patients Under Sedation
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Voluntary patients over 18 years of age
- ASA (American Society of Anaesthesiologists) risk scores I to III
You will not qualify if you...
- Intubation
- Tracheostomies
- Need for oxygen therapy due to preexisting disease
- Pregnancy
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Ankara Bilkent City Hospital
Ankara, Turkey (Türkiye), 06800
Actively Recruiting
Research Team
S
Sümeyye Demirhan, MD
CONTACT
C
Cihan Doger, Assoc Prof
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here